calendar
7,405 catalysts · 3,350 8k filing · 1,080 grant · 1,000 device adverse event · 579 earnings · 519 approval · 408 device 510k
7,405 catalysts · 3,350 8k filing · 1,080 grant · 1,000 device adverse event · 579 earnings · 519 approval · 408 device 510k
Sponsor: ORGANON LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: IMPAX. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: RHYTHM. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: IMPAX. Form: INJECTABLE. Route: INTRAMUSCULAR, SUBCUTANEOUS
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: FRESENIUS KABI USA. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: VIWIT PHARM. Form: INJECTABLE. Route: INJECTION
Product code: MOF. Advisory committee: Cardiovascular. Type: Special
Product code: MRW. Advisory committee: Unknown. Type: Traditional
Product code: KDI. Advisory committee: Gastroenterology, Urology. Type: Special
Product code: FBN. Advisory committee: Gastroenterology, Urology. Type: Traditional
Product code: ITI. Advisory committee: Physical Medicine. Type: Traditional
Product code: ELW. Advisory committee: Dental. Type: Traditional
Product code: QKB. Advisory committee: Radiology. Type: Special
Product code: HRS. Advisory committee: Orthopedic. Type: Special
Product code: LPL. Advisory committee: Ophthalmic. Type: Traditional
Product code: ILY. Advisory committee: Physical Medicine. Type: Traditional
Product code: KGN. Advisory committee: Unknown. Type: Special
Product code: DQX. Advisory committee: Cardiovascular. Type: Special
Supplement type: Normal 180 Day Track. Product code: PLS. Advisory committee: PA. Decision: APPR
Supplement type: 30-Day Notice. Product code: NEK. Advisory committee: OR. Decision: OK30
Supplement type: 30-Day Notice. Product code: OZP. Advisory committee: CH. Decision: OK30
Supplement type: 30-Day Notice. Product code: NPZ. Advisory committee: DE. Decision: OK30
Supplement type: Normal 180 Day Track No User Fee. Product code: QCD. Advisory committee: CH. Decision: APPR
Supplement type: 30-Day Notice. Product code: SFI. Advisory committee: CH. Decision: OK30
Supplement type: 30-Day Notice. Product code: NGV. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: ONU. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: MPW. Advisory committee: OR. Decision: OK30
Supplement type: Special (Immediate Track). Product code: MER. Advisory committee: GU. Decision: APPR
CA grant. $385,333. PI: Edward Bo-yi Chuong
CA grant. $437,654. PI: Jason A. Hanna
CA grant. $403,686. PI: Christopher J. Halbrook
HL grant. $74,631. PI: Hunter B Moore
Sponsor: PH HEALTH. Form: INJECTABLE. Route: INJECTION
Sponsor: GLAND. Form: INJECTABLE. Route: INJECTION
Sponsor: GLAND. Form: INJECTABLE. Route: INJECTION
Sponsor: MERZ PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: MAP77. Form: SOLUTION. Route: ORAL
Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION
Sponsor: GLAXOSMITHKLINE LLC. Form: SUSPENSION. Route: ORAL
Sponsor: ALEMBIC. Form: TABLET. Route: ORAL
Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: VIATRIS. Form: INJECTABLE. Route: INTRAMUSCULAR
Sponsor: TORRENT PHARMS. Form: TABLET, CHEWABLE. Route: ORAL
Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL
Sponsor: QUAGEN. Form: SOLUTION. Route: ORAL
Product code: KPE. Advisory committee: General Hospital. Type: Traditional
Product code: OBP. Advisory committee: Neurology. Type: Traditional
Product code: EMA. Advisory committee: Dental. Type: Traditional